eli lilly lawsuit tirzepatide Weight loss drug lawsuit: Mounjaro maker files suit over compounded products Eli Lilly just lost a

It occurs because the medication slows gastric emptying and intestinal transit time, which allows more water to be absorbed from stool and makes bowel movements harder to pass

We prescribe semaglutide (the active ingredient in Ozempic and Wegovy) or tirzepatide (the active ingredient in Mounjaro and Zepbound) both FDA-approved GLP-1 medications for chronic weight management

However, like any medication, it is essential to use Ozempic as directed by a healthcare professional

Together, we can navigate these challenges and find the best path forward for your health and well-being

At this time, patients have to be at least 18 years old to participate in the program

pmid:37552706 46